Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton London Docklands Riverside Hotel

Sep 19, 2018 8:00 AM - Sep 20, 2018 5:00 PM

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Global Clinical Trials Transparency Conference

Session 2: Sharing and Using Deidentified Individual Participant Data (IPD)

Session Chair(s)

Rebecca  Williams, PharmD, MPH

Rebecca Williams, PharmD, MPH

Senior Clinical Trials Subject Matter Expert

Essex, an Emmes Company, United States

Learn how data repositories such as Vivli and are advancing access to IPD for research purposes and how specific companies are using this resource to support their own disclosure policies. This session will also include a case study describing how academic researchers are using IPD to address questions intended to have clinical impact. Specific features of these data sharing platforms, as well as issues in using IPD will be described.


Benjamin  Rotz, RPh

Sponsors/Funders Providing Access to IPD through Benjamin Rotz, RPh

Senior Advisor Global Medical Strategy and Operations

Eli Lilly and Company, United States

Rebecca  Li, PhD

Vivli – A global data sharing platform: Rebecca Li, PhD

Executive Director, Center for Global Clinical Research Data

Vivli , United States

Sarah  Nevitt

Sarah Nevitt

Department of Biostatistics

University of Liverpool, United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.